Brief: Shenzhen Hepalink Pharma Says 6-Month Net Profit Up 51.2% Y/Y
29/08/2022 10:40
Aug 29 (Reuters) - Shenzhen Hepalink Pharmaceutical Group Co
Ltd 002399.SZ :
* SAYS 6-MONTH NET PROFIT UP 51.2% Y/Y
Source text http://www.szse.cn/disclosure/listed/bulletinDetail/index.html?f8e68818-7af0-436e-af74-abd4baff4de3
Further company coverage: 002399.SZ
(Reporting by Hong Kong newsroom)
((meg.shen@thomsonreuters.com; 852-39525805;))
Recent news on Shenzhen Hepalink Pharmaceutical Co
See all newsBrief: Shenzhen Hepalink Pharmaceutical Group Says Enoxaparin Sodium Injection Obtains New Manufacturer Authorization From EMA
Brief: Shenzhen Hepalink Pharmaceutical Group Posts QTRLY Net Profit Attributable Of RMB156.6 Million
Brief: Shenzhen Hepalink Pharmaceutical Posts Profit Attributable RMB646.7 Million For Year
Brief: Shenzhen Hepalink Pharmaceutical Says Enoparin Approved In Argentina
Brief: Shenzhen Hepalink Pharmaceutical Says H1710 Injection Received Approval For From NMPA